Exchange Traded Concepts, LLC Meridian Bioscience Inc Transaction History

Exchange Traded Concepts, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 17, 2023	BUY	$31.15 - $33.39 $22,801 - $24,441	732 Added 1.33%	55,898 $1.86 Million
Q3 2022 Oct 07, 2022	BUY	$30.9 - $33.55 $464,983 - $504,860	15,048 Added 37.51%	55,166 $1.74 Million
Q2 2022 Jul 20, 2022	SELL	$23.75 - $31.69 $118,845 - $158,576	-5,004 Reduced 11.09%	40,118 $1.22 Million
Q1 2022 Apr 26, 2022	BUY	$19.97 - $26.94 $901,086 - $1.22 Million	45,122 New	45,122 $1.17 Million
Q3 2021 Oct 18, 2021	SELL	$17.35 - $22.5 $789,477 - $1.02 Million	-45,503 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$18.01 - $28.32 $77,983 - $122,625	4,330 Added 10.52%	45,503 $1.01 Million
Q1 2021 Apr 20, 2021	BUY	$19.76 - $29.89 $276,481 - $418,220	13,992 Added 51.48%	41,173 $1.08 Million
Q4 2020 Jan 19, 2021	BUY	$15.73 - $21.66 $41,810 - $57,572	2,658 Added 10.84%	27,181 $508,000
Q3 2020 Oct 30, 2020	SELL	$13.54 - $26.41 $70,353 - $137,226	-5,196 Reduced 17.48%	24,523 $416,000
Q2 2020 Jul 15, 2020	BUY	$7.84 - $23.29 $232,996 - $692,155	29,719 New	29,719 $692,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.